Chip Shockwave: AMD, Marvell, and Kura Oncology Stocks Surge

AMD, Marvell, and Kura Oncology stocks sent a shockwave through the markets today, surprising investors with both growth prospects and industrial competition dynamics.

Chip Shock: AMD’s 12% Surge

■AMD’s 12% increase moved the stock from $120 to $135, marking a significant step toward a $100 billion market cap.

■The company’s new $5,000 chip series against NVIDIA has boosted demand by 18%.

Data‑Center Vision: Marvell’s 8% Momentum

■Marvell’s 8% rise from $35 to $38 attracted $8 billion of investor interest.

■Its NVMe SSD technology supports a $3.5 billion market share goal for 2025.

Oncology Growth Signals: Kura Oncology

■Kura Oncology’s 7% jump from $3.2 to $3.4.

■The firm plans to expand its $1.5 billion CAR‑T therapy portfolio.

Retail Slowdown: Dick’s Sporting Goods

■Dick’s Sporting Goods fell 4%, dropping from $95 to $91, impacting its $7.8 billion market cap.

■Sales are projected to decline 3% in 2024, affecting a $2.1 billion net‑profit forecast.

Dr. Yaman Ege: "These abrupt moves in the semiconductor market, coupled with TSMC’s planned 15% production capacity increase for 2025 and ASML’s new EUV machine technologies, will reinforce the competitive advantage of leaders like Nvidia and AMD. At the same time, the China‑US rare‑earth element war adds a new risk dimension to markets, indirectly impacting firms such as Kura Oncology.